Cytek Biosciences, a US-based provider of instruments for researchers and clinicians, has secured an undisclosed sum in a round co-anchored by two China-focused funds while Chinese brand promotion platform Shopal raised Rmb200 million ($29.17 million) in Series B+ round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
